Please login to the form below

Not currently logged in
Email:
Password:

Thomas Wellner appointed CEO of CML Healthcare

Former president and general manager of Lilly Germany joins Canada-based provider of laboratory testing services

Former president and general manager of Lilly Germany Thomas Wellner has been appointed CEO of CML Healthcare.

Wellner takes over from company chair Patrice Merrin, who had been interim CEO of the Canada-based provider of laboratory testing services since May, 2011.

"We are very pleased to welcome Tom Wellner to CML,” said Merrin. “During the course of his career, Tom has had exposure to numerous healthcare and payor systems as well as to the critical interface of diagnostics, physicians, patients and treatment regimens.”

Prior to his new appointment, Wellner was president and CEO of Canadian biopharma Therapure Biopharma, from 2008 to 2011.

Before his time at Theapure he spent a total of 20 years at Eli Lilly & Company holding senior roles in China, the US, the UK and Latin America.

These included executive director marketing and sales, European Operations at Eli Lilly and Company and director marketing at Eli Lilly Canada, as well as his position in Germany.

9th February 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SpotMe

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics